Celltrion Takes Trio Of GGB Awards In Milan
As Sandoz And Dr Reddy’s Also Take Home Two Awards Each
Celltrion has taken home three awards while Sandoz and Dr Reddy’s have walked away with two prizes each, after winners were announced at the Global Generics & Biosimilars Awards 2021, held in Milan, Italy, on 10 November.
You may also be interested in...
UK-based charity International Health Partners says the value of donations to its latest ‘Big Give’ appeal will be doubled in early December, as it continues to work to provide healthcare access to people in disaster-hit and vulnerable communities.
In the wake of a major deal to acquire GlaxoSmithKline’s cephalosporins business, Sandoz CEO Richard Saynor has set out why the company’s unique position means that antibiotics are an important area for investments, in an exclusive interview with Generics Bulletin.
Sandoz has completed the acquisition of GSK’s cephalosporin antibiotics business which includes the Zinnat, Zinacef and Fortum brands in more than 100 markets. Commenting as the deal closed, Sandoz CEO Richard Saynor emphasized the importance of investing in antibiotics.